Clinical Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative UG3/UH3 Clinical Trial Required)
ID: 358851Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Small Businesses

Funding Category

Health

Funding Instrument

Cooperative Agreement

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/358851
Timeline
    Description

    The National Institutes of Health (NIH) is preparing to solicit applications for the establishment of a Clinical Coordinating Center (CCC) dedicated to multi-site investigator-initiated clinical trials, including efficacy, comparative effectiveness, and implementation research. The objective of this opportunity is to develop a comprehensive scientific and operational plan for the clinical trials that align with the research mission of the National Heart, Lung, and Blood Institute (NHLBI) and meet the NIH definition of a clinical trial. This cooperative agreement will follow a bi-phasic, milestone-driven award mechanism and requires the submission of both a CCC application and a collaborating Data Coordinating Center (DCC) application by the same deadline. Interested applicants can reach out to Dr. Yves Rosenberg at rosenbey@nhlbi.nih.gov or call 301-435-0550 for further information. The estimated synopsis post date is July 11, 2025, with applications expected to close on October 13, 2025, and awards anticipated by May 1, 2026.

    Point(s) of Contact
    Yves Rosenberg, MD, MPH Division of Cardiovascular Sciences National Heart, Lung, and Blood Institute (NHLBI)
    (301) 435-0550
    rosenbey@nhlbi.nih.gov
    Files
    No associated files provided.
    Similar Opportunities
    Data Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative U24 Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH) is seeking applications for a Data Coordinating Center (DCC) to support multi-site investigator-initiated clinical trials through a cooperative agreement. The DCC will be responsible for project coordination, administration, data management, and biostatistical support for trials that may involve various therapeutic, behavioral, and prevention strategies relevant to the NHLBI's research mission. This opportunity is crucial for advancing clinical research and ensuring effective collaboration among investigators. Interested small businesses should prepare to submit their applications alongside a collaborating Clinical Coordinating Center (CCC) application by the due date, with the estimated award date set for May 1, 2026. For further inquiries, potential applicants can contact Dr. Yves Rosenberg at rosenbey@nhlbi.nih.gov or by phone at 301-435-0550.
    Clinical Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Natural Products (Collaborative UG3/UH3 Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity for cooperative agreements to establish a Clinical Coordinating Center (CCC) for multi-site, investigator-initiated clinical trials focused on the effects of natural products, such as botanicals and dietary supplements. Applicants are required to develop a comprehensive scientific and operational plan for the clinical trial, including project management, participant recruitment, and performance milestones, while also submitting a companion Data Coordinating Center (DCC) application. This initiative aims to generate robust clinical data to inform integrative health approaches and public health strategies, with applications opening on January 20, 2025, and closing on July 14, 2026. For further details, interested parties can contact NIH Grants Information at grantsinfo@nih.gov or visit the opportunity's webpage at https://grants.nih.gov/grants/guide/pa-files/PAR-24-312.html.
    Clinical Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Mind and Body Interventions (Collaborative UG3/UH3 Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Center for Complementary and Integrative Health (NCCIH), is offering a funding opportunity for the establishment of a Clinical Coordinating Center (CCC) to support multi-site investigator-initiated clinical trials focused on mind and body interventions. Applicants are required to develop comprehensive plans that include project management, participant recruitment, and data analysis, while collaborating with a corresponding Data Coordinating Center (DCC) to ensure the trials are scientifically robust and aligned with NCCIH's research priorities. This initiative aims to explore the efficacy and effectiveness of complementary health approaches, emphasizing the inclusion of diverse populations and the necessity for a detailed plan to enhance diversity in research teams and subjects. Interested applicants must submit their proposals by January 20, 2025, and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries. For more details, please refer to the full announcement available at https://grants.nih.gov/grants/guide/pa-files/PAR-24-275.html.
    Data Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Mind and Body Interventions (Collaborative U24 Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Center for Complementary and Integrative Health (NCCIH), is inviting applications for a Data Coordinating Center (DCC) to support multi-site, investigator-initiated clinical trials focused on mind and body interventions. The DCC will be responsible for project coordination, administrative support, data management, and biostatistical analysis for Phase III clinical trials, and must be submitted alongside a Clinical Coordinating Center (CCC) proposal. This initiative is crucial for advancing research in complementary and integrative health strategies that address public health challenges, emphasizing participant diversity and data integrity. Interested applicants should note that the application deadline is January 20, 2025, with a funding period of up to 7 years, and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Clinical Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Natural Products (Collaborative UG3/UH3 Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity for the establishment of a Clinical Coordinating Center (CCC) to support multi-site investigator-initiated clinical trials focused on natural products, such as botanicals and dietary supplements. Applicants are required to submit a comprehensive plan detailing project management, participant recruitment, and clinical trial execution, while also ensuring alignment with NIH standards. This initiative emphasizes the importance of evidence-based research in natural products and mandates the submission of a corresponding Data Coordinating Center (DCC) proposal to oversee data management and analysis. Interested applicants should note that the application deadline is July 15, 2026, and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries. For additional details, applicants can refer to the full announcement available at https://grants.nih.gov/grants/guide/pa-files/PAR-24-123.html.
    Natural Product Multi-Site Clinical Trial Data Coordinating Center (Collaborative U24 Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity for the Natural Product Multi-Site Clinical Trial Data Coordinating Center (DCC) through a cooperative agreement mechanism. This initiative invites applications for a DCC that will collaborate with a Clinical Coordinating Center (CCC) to conduct multi-site clinical trials focused on the efficacy and effectiveness of natural products, requiring simultaneous submission of both applications. The program emphasizes the importance of maintaining data integrity, promoting diversity in participant recruitment, and achieving specific milestones for continued funding, while also necessitating a Plan for Enhancing Diverse Perspectives (PEDP) to ensure inclusivity in research. Interested applicants can find more information and application details on the NIH grants website, with a submission deadline of July 14, 2026, and a contact email for inquiries at grantsinfo@nih.gov.
    HeartShare 2.0: Refining Heart Failure Subtypes and Treatment Targets for Personalized Clinical Trials - Clinical Trial Center and Clinical Centers (U01 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is set to announce a funding opportunity titled "HeartShare 2.0: Refining Heart Failure Subtypes and Treatment Targets for Personalized Clinical Trials," aimed at establishing a Clinical Trial Center (CTC) and up to seven Clinical Centers (CCs) focused on heart failure with preserved ejection fraction (HFpEF). The initiative seeks to coordinate precision clinical trial activities, including master protocol development, project management, and recruitment oversight, while the CCs will be responsible for recruiting and retaining heart failure patients and conducting deep phenotyping protocols. This program is crucial for advancing personalized treatment approaches in heart failure, and while applications are not currently being solicited, interested parties are encouraged to prepare collaborative proposals ahead of the estimated synopsis posting on October 15, 2025, with a projected award date of May 1, 2026. For further inquiries, applicants can contact the HeartShare Team via email at nhlbiheartshare@mail.nih.gov.
    Cardiothoracic Surgical Trials Network (CTSN) Linked Clinical Research Centers
    National Institutes of Health
    The National Institutes of Health (NIH) is preparing to publish a Notice of Funding Opportunity (NOFO) for the Cardiothoracic Surgical Trials Network (CTSN) Linked Clinical Research Centers, aimed at expanding an international cardiac surgery research platform. This initiative will focus on integrating various areas of research, including interventional cardiology, peri-operative care, dissemination and implementation science, circadian medicine, and mechanistic science, to enhance the health outcomes of adults with cardiovascular disease and related neurologic complications. The platform will also serve as a training ground for future clinical trialists and implementation researchers, fostering collaboration among academia, small businesses, and other stakeholders. While applications are not currently being solicited, interested parties are encouraged to prepare for future submissions, with the estimated synopsis post date set for February 2, 2026, and the estimated project start date anticipated for January 1, 2027. For further inquiries, potential applicants can contact Dr. Kathleen Fenton at kathleen.fenton@nih.gov or by phone at 301-221-7865.
    Opportunities for Collaborative Research at the NIH Clinical Center
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a federal grant opportunity titled "Opportunities for Collaborative Research at the NIH Clinical Center," aimed at supporting collaborative translational research projects that enhance the application of basic biological discoveries to clinical settings. This program encourages partnerships between NIH intramural investigators and extramural researchers to accelerate patient-centric translational research, focusing on understanding disease processes and developing new therapeutic interventions, diagnostics, or prevention strategies. Interested small businesses can apply for this cooperative agreement, with no cost-sharing requirement, and should note that the estimated synopsis post date is September 1, 2025, with a closing date of December 12, 2025. For further inquiries, applicants can contact Dr. David J. Eckstein at 301-496-4121 or via email at ClinicalCtrPartner@mail.nih.gov.
    Single-Site Investigator-Initiated Clinical Trials (R61/R33 Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH) is preparing to release a Notice of Funding Opportunity (NOFO) for the R61/R33 grant program, aimed at supporting investigator-initiated single-site clinical trials. This initiative encourages applications that focus on various types of clinical trials, including efficacy, comparative effectiveness, and implementation research, particularly those employing innovative trial designs such as adaptive and Bayesian methods. The trials must align with the research mission of the National Heart, Lung, and Blood Institute (NHLBI) and adhere to the NIH definition of a clinical trial. Interested small businesses are advised to begin developing collaborative projects in anticipation of the application period, which is expected to open following the estimated synopsis post date of July 11, 2025, with applications due by October 13, 2025. For further inquiries, potential applicants can contact Dr. Yves Rosenberg at rosenbey@nhlbi.nih.gov or by phone at 301-435-1292.